Literature DB >> 7229379

Lymphoid cell surface receptor for Moloney leukemia virus envelope glycoprotein gp71. I. Binding characteristics.

J Choppin, L Schaffar-Deshayes, P Debré, J P Lévy.   

Abstract

The characteristics of Moloney leukemia virus (M-MuLV) gp71 binding on lymphoid cells have been studied by a very sensitive assay. Analysis of the results indicated the presence of 1 class of high affinity binding sites (Ka = 1.2 X 10(9) M-1) on BALB/c thymus cells. The total number of binding sites was estimated around 1.3 X 10(4) per thymus cell. No significative differences were observed for the binding of Moloney leukemia virus gp71 on thymus cells from different inbred strains of mice, suggesting that the genetic susceptibility to Moloney leukemia virus infection does not depend on the presence of gp71 receptor on the target cells. On the other hand, it seems that M-MuLV gp71 binds preferentially on T cells, which are the final target of Moloney leukemia virus-induced transformation. Very little binding was found on Moloney, Rauscher, or x-ray-induced lymphoma cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7229379

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein.

Authors:  E Bachrach; M Marin; M Pelegrin; G Karavanas; M Piechaczyk
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells.

Authors:  H Yu; N Soong; W F Anderson
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

3.  Encephalomyocarditis virus can bind to and transfect non-permissive cells.

Authors:  S T Donta; J D Shanley; P Damiano-Burbach
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein.

Authors:  J L Battini; P Rodrigues; R Müller; O Danos; J M Heard
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus.

Authors:  Samuel L Murphy; Maeran Chung-Landers; Marek Honczarenko; Glen N Gaulton
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Retrovirus infection: effect of time and target cell number.

Authors:  J R Morgan; J M LeDoux; R G Snow; R G Tompkins; M L Yarmush
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Characterization of murine-specific leukemia virus receptor from L cells.

Authors:  P A Johnson; M R Rosner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

8.  Identification of a putative receptor for subgroup A feline leukemia virus on feline T cells.

Authors:  A K Ghosh; M H Bachmann; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

9.  Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis.

Authors:  M J Kadan; S Sturm; W F Anderson; M A Eglitis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Recognition of a leukemia-related antigen by an antiidiotypic antiserum to an anti-gp70 monoclonal antibody.

Authors:  B Ardman; R H Khiroya; R S Schwartz
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.